Laura Bae
Chief Executive Officer @Silver Spur Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Chief Executive Officer @Silver Spur Therapeutics
Los Angeles, CA, US
Led the company from incubation as a university spinout, successfully preparing and closing the pre-seed funding roundDirect all aspects of strategy, operations, and execution for a preclinical-stage biotech developing therapies for high unmet need indications (ADPKD)Build and manage cross-functional teams across science, clinical, regulatory, CMC, operations, and financeDevelop company-wide financial planning, budgeting, and resource allocation frameworks to ensure capital efficiency and strategic alignmentEstablish and maintain partnerships with CROs, research institutions, and industry collaborators to accelerate program timelinesSource and manage partnership opportunities, overseeing the pipeline to drive strategic growth
EDUCATION
University of Nevada-Las Vegas
Bachelors
ABOUT LAURA BAE
Founder & CEO with a track record of building high-growth, capital-efficient companies from the ground up. I bring an operator’s mindset to life sciences: translating complex science into executable strategies, building teams that scale, and aligning capital, operations, and R&D to maximize impact.At Silver Spur Therapeutics, I lead all aspects of strategy, operations, and execution for a preclinical-stage biotech developing therapies for high unmet need indications (ADPKD). I built the company from incubation as a university spinout, closed the pre-seed funding round, assembled a world-class advisory board of KOLs, and established strategic partnerships with CROs, research institutions, and industry collaborators to accelerate program timelines.Previously, at LoanSnap, I drove company-wide operational and financial strategy across Product, Engineering, Capital Markets, Operations, Finance, and Sales, leading cross-functional expansions, building unit economics models that improved margins and reduced losses, and managing investor due diligence for a Series B round valued at $200M+. I also developed ROI and impact frameworks that informed strategic resource allocation and capital efficiency.I am passionate about building science-driven companies with operational rigor, strong capital discipline, and the strategic vision to deliver meaningful outcomes for patients, investors, and partners.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.